| Kurt Henry Fluhler, DPT | |
|
101 Brookside Ave, Chester, NY 10918-1003 | |
| (845) 469-2224 | |
| Not Available |
| Full Name | Kurt Henry Fluhler |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 101 Brookside Ave, Chester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356011068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ati Holdings Llc | 9537112719 | 375 |
News Archive
Publicis Groupe announced today that it has agreed to acquire a majority stake in a leading healthcare advertising agency in Mumbai, India-Watermelon Healthcare Communications Private Limited.
A new study seeks to explore the factors associated with the diagnosis in children. The ability to rapidly diagnose COVID-19 in this age group is essential not only for monitoring progressive disease in individual children, but to avert further transmission chains.
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. The study, in mice, suggests that a reduction in insulin production possibly caused by fewer carbohydrates may stall tumor growth.
A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
› Verified 9 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061020000349 |
News Archive
Publicis Groupe announced today that it has agreed to acquire a majority stake in a leading healthcare advertising agency in Mumbai, India-Watermelon Healthcare Communications Private Limited.
A new study seeks to explore the factors associated with the diagnosis in children. The ability to rapidly diagnose COVID-19 in this age group is essential not only for monitoring progressive disease in individual children, but to avert further transmission chains.
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. The study, in mice, suggests that a reduction in insulin production possibly caused by fewer carbohydrates may stall tumor growth.
A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
› Verified 9 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061023000321 |
News Archive
Publicis Groupe announced today that it has agreed to acquire a majority stake in a leading healthcare advertising agency in Mumbai, India-Watermelon Healthcare Communications Private Limited.
A new study seeks to explore the factors associated with the diagnosis in children. The ability to rapidly diagnose COVID-19 in this age group is essential not only for monitoring progressive disease in individual children, but to avert further transmission chains.
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. The study, in mice, suggests that a reduction in insulin production possibly caused by fewer carbohydrates may stall tumor growth.
A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kurt Henry Fluhler, DPT 16 Maybrook Rd Ste L, Campbell Hall, NY 10916-2741 Ph: () - | Kurt Henry Fluhler, DPT 101 Brookside Ave, Chester, NY 10918-1003 Ph: (845) 469-2224 |
News Archive
Publicis Groupe announced today that it has agreed to acquire a majority stake in a leading healthcare advertising agency in Mumbai, India-Watermelon Healthcare Communications Private Limited.
A new study seeks to explore the factors associated with the diagnosis in children. The ability to rapidly diagnose COVID-19 in this age group is essential not only for monitoring progressive disease in individual children, but to avert further transmission chains.
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers. The study, in mice, suggests that a reduction in insulin production possibly caused by fewer carbohydrates may stall tumor growth.
A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
Published online on Aug. 7, 2011, the journal Nature Medicine reports that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
› Verified 9 days ago
Nicole Lee Jacklitsch, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Jackie Ct, Chester, NY 10918 Phone: 845-544-3392 | |
Thomas Derian Ogrodnik, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 | |
Ms. Mae Resa Card, P.T., D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Overlook Trail, Chester, NY 10918 Phone: 315-512-1773 Fax: 315-512-1774 | |
Dr. Samuel D O'keefe, PT DPT CSCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 | |
Isabel Blanco, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Gibson Hill Rd, Chester, NY 10918 Phone: 845-469-5092 | |
Ms. Isabel A. Blanco, PT, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Gibson Hill Road, Chester, NY 10918 Phone: 845-469-5092 | |
Austin Frost, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Brookside Ave, Chester, NY 10918 Phone: 845-469-2224 |